CTLA4 and neoplasm: The immune checkpoint molecules, including cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4) and programmed death receptor‐1 and its ligand (PD‐1/PD‐L1), play a significant role in facilitating immune evasion by tumor cells.